Oncolix, Inc. Accretion Expense
Oncolix, Inc. reported Accretion Expense of $2.68 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2018-11-19
- Oncolix, Inc. accretion expense for the quarter ending 2018-09-30 was $455.97K, a 36.27% decline year-over-year.
- Oncolix, Inc. accretion expense for the quarter ending 2018-06-30 was $1.23M, a 402.82% increase year-over-year.
- Oncolix, Inc. accretion expense for the quarter ending 2018-03-31 was $994.46K, a 509.80% increase year-over-year.
- Oncolix, Inc. accretion expense for the quarter ending 2017-12-31 was $457.39K, a 926.72% increase year-over-year.
- Oncolix, Inc. accretion expense for fiscal 2017 was $1.58M, a 3012.98% increase from fiscal 2016.
- Oncolix, Inc. accretion expense for fiscal 2016 was $50.75K.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|---|
| 2018-09-30 | $455.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-19 | $1.68M derived: sum of 2 quarters · filed 2018-11-19 | $2.68M 10-Q · filed 2018-11-19 | $3.13M derived: sum of 4 quarters · filed 2018-11-19 |
| 2018-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $2.22M 10-Q · filed 2018-08-09 | $2.68M derived: sum of 3 quarters · filed 2018-08-09 | $3.39M derived: sum of 4 quarters · filed 2018-11-19 |
| 2018-03-31 | $994.46K 10-Q · filed 2018-05-14 | $1.45M derived: sum of 2 quarters · filed 2018-05-14 | $2.17M derived: sum of 3 quarters · filed 2018-11-19 | $2.41M derived: sum of 4 quarters · filed 2018-11-19 |
| 2017-12-31 | $457.39K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $1.17M derived: sum of 2 quarters · filed 2018-11-19 | $1.42M derived: sum of 3 quarters · filed 2018-11-19 | $1.58M 10-K · filed 2018-03-14 |
| 2017-09-30 | $715.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-19 | $959.33K derived: sum of 2 quarters · filed 2018-11-19 | $1.12M 10-Q · filed 2018-11-19 | $1.17M derived: sum of 4 quarters · filed 2018-11-19 |
| 2017-06-30 | $243.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $406.95K 10-Q · filed 2018-08-09 | $451.50K derived: sum of 3 quarters · filed 2018-08-09 | |
| 2017-03-31 | $163.08K 10-Q · filed 2018-05-14 | $207.63K derived: sum of 2 quarters · filed 2018-05-14 | ||
| 2016-12-31 | $44.55K derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-14 | $50.75K 10-K · filed 2018-03-14 | ||
| 2016-09-30 | $6.20K 10-Q/A · filed 2017-11-24 |